Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Aug. 27, 2014 -- Obesity costs the U.S. health-care system close to $150 billion a year -- not terribly surprising when you consider that more than a third of American adults are obese.

That number, from 2009, is the latest reported by the CDC. Other estimates are even higher, and those costs are expected to rise.

And yet, less than 1% of that $150 billion goes toward prescription medications approved to treat obesity. Although the highly anticipated approval of two newer anti-obesity drugs, Belviq and Qsymia, has bumped up sales, neither is anywhere close to a blockbuster.

In 2013, U.S. sales of anti-obesity drugs totaled about $114 million, according to IMS Health, an international information, services, and technology company. By comparison, U.S. sales of drugs to treat diabetes, one type of which is linked to obesity, totaled about $22 billion.

Obesity experts blame lackluster sales of the drugs on several things: doctors’ lack of training in how to treat obesity, concerns about the medications’ safety, and a lack of insurance coverage.

“We still as a society believe that the things that work for preventing obesity are going to work for treatment,” says Steven Smith, MD, president of The Obesity Society, a scientific organization. “We have this inherent belief that willpower’s going to help with these kinds of issues.” But, Smith says, diet and exercise alone “by and large are ineffective for treating obesity.”

Most obese people need the help of anti-obesity medication, yet few are getting prescriptions for them, Smith says. Doctors are more likely to advise obese patients to eat less and move more or, at the other end of the spectrum, refer them for weight-loss surgery than prescribe medication, he says. Smith is the founding scientific director of the Translational Research Institute for Metabolism and Diabetes at Florida Hospital in Orlando.

“The gap in the middle is clear,” says Smith, who was involved in all phases of clinical trials of Belviq, the newest anti-obesity medication on the U.S. market. He spoke on behalf of its manufacturer, Arena Pharmaceuticals, at an FDA advisory committee meeting on the drug. “We are not educating physicians about how to manage obesity in a busy clinical practice.”

Healthy Recipe Finder

Browse our collection of healthy, delicious recipes, from WebMD and Eating Well magazine.

Top searches: Chicken, Chocolate, Salad, Desserts, Soup

Heart Rate Calculator

Ensure you're exercising hard enough to get a good workout, but not strain your heart.

While you are exercising, you should count between...